Cancer, Advanced Completed Phase 1 Trials for Docetaxel (DB01248)

Also known as: Advanced Cancer / Cancer / Neoplasm malignant / Malignant neoplasm NOS / Cancer NOS / Malignant tumor / Malignant tumour / Cancer (NOS) / Malignant neoplasm without specification of site

DBCOND0041606 (Cancer, Advanced)Completed1 IdentifierTitlePurposeDrugs
NCT00664170A Bioequivalence Study of Docetaxel for Injectable Emulsion (ANX-514) in Patients With Advanced CancerTreatment
NCT00798252Ascending Multiple-Dose Study of Brivanib Alaninate in Combination With Chemotherapeutic Agents in Subjects With Advanced CancersTreatment
NCT00833326A Study of ARRY-334543 and Docetaxel in Patients With Advanced CancerTreatment
NCT01054313Docetaxel and Sirolimus in Patients With Advanced MalignanciesTreatment